Active Ingredient: LATANOPROST
Proprietary Name: LATANOPROST
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 0.005%
Reference Listed Drug: No
Reference Standard: No
TE Code: AT
Application Number: A202077
Product Number: 001
Approval Date: Feb 11, 2013
Applicant Holder Full Name: CARNEGIE PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information